Well, it's the only approved cancer immunotherapy, but it's not who we should be comparing PRR too.
NWBO (dendritic GMB vaccine) has gone up around 100% in the last couple of days, most likely based on an announcement regarding the manufacturing approval in Germany at the Fraunhofer Institute.
Sound familiar? Yes, the same institute that manufactures CVac gave Prima a grant.
http://www.izi.fraunhofer.de/zelltechnik-gmp-projekte.html?&L=1&print=1
There are other interesting players researching immunotherapy, and while all quite different to each other and Cvac, I find it more useful to compare Prima to them than DNDN.
- Forums
- ASX - By Stock
- IMM
- prima biomed to release interim cvac clinical
prima biomed to release interim cvac clinical , page-27
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $537.4M |
Open | High | Low | Value | Volume |
37.0¢ | 38.3¢ | 36.5¢ | $1.060M | 2.841M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 48648 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 13814 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 48648 | 0.365 |
7 | 164694 | 0.360 |
4 | 31498 | 0.355 |
7 | 161310 | 0.350 |
3 | 12221 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 13814 | 2 |
0.375 | 175836 | 7 |
0.380 | 137322 | 5 |
0.385 | 53062 | 4 |
0.390 | 197301 | 5 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online